R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma

PHASE3CompletedINTERVENTIONAL
Enrollment

600

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Diffuse Large Cell Lymphoma
Interventions
DRUG

Darbepoetin alfa

prophylactic administration of darbepoetin alfa in experimental arm

Trial Locations (14)

31059

Hématologie CHU Purpan, Toulouse

33300

Polyclinique Bordeaux Nord, Bordeaux

51092

Centre Hospitalier Robert Debré, Reims

59000

Hématologie CHU de Lille, Lille

69008

Centre Léon Bérard, Lyon

69495

Service d'Hématologie - Centre Hospitalier Lyon-Sud, Pierre-Bénite

75010

Hôpital Saint Louis, Paris

75743

Hématologie Adultes - Hôpital Necker, Paris

76038

Centre Henri Becquerel, Rouen

94010

Hôpital Henri Mondor, Créteil

Unknown

Université de Gent, Ghent

Groupe d'Etude des Lymphomes de l'adulte, Mont-Godinne

Institut Gustave Roussy, Villejuif

Schweirische Arbeitsgruppe fur klinische Krebsforschung, Lausanne

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Lymphoma Study Association

OTHER